Siritanaratkul, Noppadol

Top Publications

Top Publications Authored or Co-Authored by "Siritanaratkul, Noppadol"

• Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by prior treatment

  Blood, Volume 127, No. 6, Year 2016, Citations 118
• Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial

  The Lancet Haematology, Volume 3, No. 11, Year 2016, Citations 117
• Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

  The Lancet Oncology, Volume 19, No. 11, Year 2018, Citations 84
• Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial

  The Lancet Oncology, Volume 15, No. 11, Year 2014, Citations 45
• Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

  The Lancet Infectious Diseases, Volume 19, No. 9, Year 2019, Citations 24